REPORT ID 5105

United States Gastrointestinal Drugs Market Report 2017

Publish Date
20-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the United States Gastrointestinal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Gastrointestinal Drugs in these regions, from 2012 to 2022 (forecast).

United States Gastrointestinal Drugs market competition by top manufacturers/players, with Gastrointestinal Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca
    Johnson & Johnson
    Salix Pharma
    Takeda Pharma
    Eisai
    Shire
    Allergan
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Capsules
    Inhalants
    Parenterals
    Tablets
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Antacid & Anti-Ulcerant
    GIT Anti-inflammatory
    Antiemetic
    Anti-diarrhoea
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Gastrointestinal Drugs Market Report 2017
1 Gastrointestinal Drugs Overview
    1.1 Product Overview and Scope of Gastrointestinal Drugs
    1.2 Classification of Gastrointestinal Drugs by Product Category
        1.2.1 United States Gastrointestinal Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Gastrointestinal Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Capsules
        1.2.4 Inhalants
        1.2.5 Parenterals
        1.2.6 Tablets
        1.2.7 Other
    1.3 United States Gastrointestinal Drugs Market by Application/End Users
        1.3.1 United States Gastrointestinal Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Antacid & Anti-Ulcerant
        1.3.3 GIT Anti-inflammatory
        1.3.4 Antiemetic
        1.3.5 Anti-diarrhoea
        1.3.6 Other
    1.4 United States Gastrointestinal Drugs Market by Region
        1.4.1 United States Gastrointestinal Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.3 Southwest Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.5 New England Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.6 The South Gastrointestinal Drugs Status and Prospect (2012-2022)
        1.4.7 The Midwest Gastrointestinal Drugs Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Gastrointestinal Drugs (2012-2022)
        1.5.1 United States Gastrointestinal Drugs Sales and Growth Rate (2012-2022)
        1.5.2 United States Gastrointestinal Drugs Revenue and Growth Rate (2012-2022)

2 United States Gastrointestinal Drugs Market Competition by Players/Suppliers
    2.1 United States Gastrointestinal Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Gastrointestinal Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Gastrointestinal Drugs Average Price by Players/Suppliers (2012-2017)
    2.4 United States Gastrointestinal Drugs Market Competitive Situation and Trends
        2.4.1 United States Gastrointestinal Drugs Market Concentration Rate
        2.4.2 United States Gastrointestinal Drugs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Gastrointestinal Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Gastrointestinal Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Gastrointestinal Drugs Sales and Market Share by Region (2012-2017)
    3.2 United States Gastrointestinal Drugs Revenue and Market Share by Region (2012-2017)
    3.3 United States Gastrointestinal Drugs Price by Region (2012-2017)

4 United States Gastrointestinal Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Gastrointestinal Drugs Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Gastrointestinal Drugs Revenue and Market Share by Type (2012-2017)
    4.3 United States Gastrointestinal Drugs Price by Type (2012-2017)
    4.4 United States Gastrointestinal Drugs Sales Growth Rate by Type (2012-2017)

5 United States Gastrointestinal Drugs Sales (Volume) by Application (2012-2017)
    5.1 United States Gastrointestinal Drugs Sales and Market Share by Application (2012-2017)
    5.2 United States Gastrointestinal Drugs Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Gastrointestinal Drugs Players/Suppliers Profiles and Sales Data
    6.1 AstraZeneca
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Gastrointestinal Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Johnson & Johnson
        6.2.2 Gastrointestinal Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Johnson & Johnson Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Salix Pharma
        6.3.2 Gastrointestinal Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Salix Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Takeda Pharma
        6.4.2 Gastrointestinal Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Takeda Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Eisai
        6.5.2 Gastrointestinal Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Eisai Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Shire
        6.6.2 Gastrointestinal Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Shire Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Allergan
        6.7.2 Gastrointestinal Drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Allergan Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Gastrointestinal Drugs Manufacturing Cost Analysis
    7.1 Gastrointestinal Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Gastrointestinal Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Gastrointestinal Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Gastrointestinal Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Gastrointestinal Drugs Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Gastrointestinal Drugs Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Gastrointestinal Drugs Sales Volume Forecast by Type (2017-2022)
    11.3 United States Gastrointestinal Drugs Sales Volume Forecast by Application (2017-2022)
    11.4 United States Gastrointestinal Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer